Megan H Fong (Megan Fong)

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Vamsi Parimi, Woonyoung Choi, Mingxiao Feng, Megan H Fong, Jean Hoffman-Censits, Max Kates, Kara A Lombardo, Eva M Comperat, David J McConkey, Noah M Hahn, Rodrigo Salgado Esteves, Andres Matoso
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladder. Histopathology (2023)
Vamsi Parimi, Woonyoung Choi, Mingxiao Feng, Megan H Fong, Jean Hoffman-Censits, Max Kates, Kara A Lombardo, Eva M Comperat, David J McConkey, Noah M Hahn, Rodrigo Salgado Esteves, Andres Matoso
Comparison of Clinicopathological Characteristics, Gene Expression Profiles, Mutational Analysis, and Clinical Outcomes of Pure and Mixed Small Cell Carcinoma of the Bladder. Histopathology (2023)
John A Ligon, Woonyoung Choi, Gady Cojocaru, Wei Fu, Emily Han-Chung Hsiue, Teniola F Oke, Nicholas Siegel, Megan H Fong, Brian Ladle, Christine A Pratilas, Carol D Morris, Adam Levin, Daniel S Rhee, Christian F Meyer, Ada J Tam, Richard Blosser, Elizabeth D Thompson, Aditya Suru, David McConkey, Franck Housseau, Robert Anders, Drew M Pardoll, Nicolas J Llosa
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes. Journal for immunotherapy of cancer 9 (5) (2022)

Megan H Fong.css-eqlu8i{font-size:small;padding-left:4px;} (Megan Fong)